Clinical Trial Update: Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the combination of gemcitabine and docetaxel with radiation for soft tissue sarcoma of the extremities has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Soft Tissue Sarcoma | Phase 1 | Status: TERMINATED